Douglas V Dolfi

Title: Douglas V. Dolfi: Innovator in Antibody Technology

Introduction

Douglas V. Dolfi, a notable inventor based in Norristown, Pennsylvania, has made significant contributions to the field of antibody technology. With a focus on advancements that target specific proteins, his work has implications for various therapeutic applications.

Latest Patents

Dolfi holds one patent titled "Anti-CEACAM antibodies and uses thereof." This patent discusses the development of monospecific and multispecific antibodies that bind to CEACAM1, while optionally targeting CEACAM5 and/or CEACAM6. The patent outlines methods for producing these antibodies and their potential uses in various medical treatments.

Career Highlights

Douglas V. Dolfi is currently affiliated with Janssen Biotech, Inc., a leader in biopharmaceutical innovation. His role at the company allows him to engage in groundbreaking research and development, contributing to advancements in healthcare solutions.

Collaborations

Dolfi collaborates with esteemed colleagues, including Wendell Lamar B. Blackwell and Cassandra L. Lowenstein. Together, they contribute to the innovative atmosphere at Janssen Biotech, Inc., enhancing the potential for new discoveries in the field of biotechnology.

Conclusion

The contributions of Douglas V. Dolfi to the field of antibody technology are noteworthy. His patent on anti-CEACAM antibodies exemplifies the important work being done in biopharmaceutical research. As he continues to collaborate with his talented colleagues, the impact of his work is likely to grow, paving the way for future innovations in medicine.